Carta Healthcare completed the acquisition of Realyze Intelligence.

Carta Healthcare, a provider of AI-driven technology, completed the acquisition of Realyze Intelligence, a provider of clinically guided large language models, data standards, Fast Healthcare Interoperability Resources and AI. Financial terms were not disclosed. "Health systems and pharmaceutical companies invest billions annually to identify and enroll patients for clinical trials—a process that is not only costly but labor-intensive and time-consuming. High-quality, timely data is essential for accurately identifying eligible patients, yet much of it remains trapped in EHRs and other systems. We are excited to revolutionize clinical trial matching and reuse the data to enhance research, optimize care pathways and improve patient outcomes with Carta Healthcare," Aaron Brauser, Realyze Intelligence Founder and CEO.